Bio Protocol Enters V2 Phase, Users Can Earn BioXP Through Staking
Foresight News reports that Bio Protocol has entered the V2 phase and launched Launcher V2, allowing users to sell low-market-cap BioAgents, IP-Tokens, and BioDAOs. In addition, users can stake BIO and DeSci tokens to earn BioXP, and accumulate points by participating in activities. These points can be used to access new sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. Senate Democrats propose plan to end government shutdown
Ethereum validator queue surges, with over 1.5 million ETH waiting to be staked
Data: If ETH falls below $3,250, the cumulative long liquidation intensity on major CEXs will reach $801 millions.
